These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 5350555)

  • 21. Urinary excretion of delta-aminolaevulinic acid and porphobilinogen in young natives of 13,000 feet, brought to sea level.
    Carmena AO; Rivas E
    Haematologia (Budap); 1971; 5(3):249-52. PubMed ID: 5128748
    [No Abstract]   [Full Text] [Related]  

  • 22. Porphyria induced in the rabbit by diethyl 1,4-dihydro-2,4,6-trimethylpyridine-3,5-dicarboxylate. I. Excretion of 5-aminolaevulic acid, porphobilinogen, coproporphyrin and protoporphyrin.
    HAEGER-ARONSEN B
    Acta Pharmacol Toxicol (Copenh); 1961; 18():165-9. PubMed ID: 13903511
    [No Abstract]   [Full Text] [Related]  

  • 23. [Appraisal of the methods of expressing lead concentrations and porphyrin precursors in the urine].
    Iliescu S; Stavri G; Freund S; Vasilíu A
    Rev Med Chir Soc Med Nat Iasi; 1969; 73(4):955-60. PubMed ID: 5370591
    [No Abstract]   [Full Text] [Related]  

  • 24. Biochemical basis and regulatory mechanisms of porphyrin synthesis.
    Neuberger A
    Proc R Soc Med; 1968 Feb; 61(2):191-3. PubMed ID: 5637834
    [No Abstract]   [Full Text] [Related]  

  • 25. Hereditary hepatic prophyrias. Gene penetration, drug sensitivity and subdivision in the light of systematic family studies.
    With TK
    Acta Med Scand; 1969; 186(1-2):117-24. PubMed ID: 5807639
    [No Abstract]   [Full Text] [Related]  

  • 26. Biochemical effects of chloroquine therapy in porphyria cutanea tarda.
    Vogler WR; Galambos JT; Olansky S
    Am J Med; 1970 Sep; 49(3):316-21. PubMed ID: 5455563
    [No Abstract]   [Full Text] [Related]  

  • 27. Intermittent acute porphyria--demonstration of a genetic defect in porphobilinogen metabolism.
    Meyer UA; Strand LJ; Doss M; Rees AC; Marver HS
    N Engl J Med; 1972 Jun; 286(24):1277-82. PubMed ID: 5024458
    [No Abstract]   [Full Text] [Related]  

  • 28. Absorption and excretion of mercury in man. 13. Effects of mercury exposure on urinary excretion of coproporphyrin and delta-aminolevulinic acid.
    Goldwater LJ; Joselow MM
    Arch Environ Health; 1967 Sep; 15(3):327-31. PubMed ID: 6035082
    [No Abstract]   [Full Text] [Related]  

  • 29. Diagnosis and treatment of the porphyrias.
    Goldberg A
    Proc R Soc Med; 1968 Feb; 61(2):193-6. PubMed ID: 5637835
    [No Abstract]   [Full Text] [Related]  

  • 30. Conventional and preparative electrophoretic separation of some urinary porphyrins and porphyrin precursors.
    Fischl J; Eichhorn F; Ruttenberg A; Major C
    Clin Chem; 1970 Apr; 16(4):331-4. PubMed ID: 5442210
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of pyridoxine deficiency on porphyrin precursor excretion in acute intermittent porphyria.
    Elder TD; Mengel CE
    Am J Med; 1966 Sep; 41(3):369-74. PubMed ID: 5914112
    [No Abstract]   [Full Text] [Related]  

  • 32. [Porphyrins and their precursors in the urine of patients with suspected porphyria; a 16-year experience].
    Zawirska B; Kwiatkowska W; Nowojska A
    Pol Tyg Lek; 1985 Jan; 40(4):97-100. PubMed ID: 3983004
    [No Abstract]   [Full Text] [Related]  

  • 33. [Behavior of delta aminolevulinic acid and porphobilinogen after glycine load in saturnism].
    Saita G; Moreo L; Levizzani G
    Med Lav; 1967 May; 58(5):364-9. PubMed ID: 5613766
    [No Abstract]   [Full Text] [Related]  

  • 34. Excretion of porphyrins and porphyrin precursors during neuromuscular paralysis produced by dithiobiuret.
    Atchison WD; Peterson RE
    Exp Neurol; 1984 Jul; 85(1):63-8. PubMed ID: 6428932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A family study of porphyrias].
    Hänninen P
    Duodecim; 1969; 85(21):1349-55. PubMed ID: 5371715
    [No Abstract]   [Full Text] [Related]  

  • 36. Hereditary coproporphyria. Photosensitivity, jaundice and neuropsychiatric manifestations associated with pregnancy.
    Hunter JA; Khan SA; Hope E; Beattie AD; Beveridge GW; Smith AW; Goldberg A
    Br J Dermatol; 1971 Apr; 84(4):301-10. PubMed ID: 5575195
    [No Abstract]   [Full Text] [Related]  

  • 37. Defects in haem synthesis in mammalian tissues in experimental lead poisoning and experimental porphyria.
    Gibson SL; Goldberg A
    Clin Sci; 1970 Jan; 38(1):63-72. PubMed ID: 5411483
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hypertension and tachycardia in acute intermittent porphyria].
    Schley G; Bock KD; Hocevar V; Merguet P; Rausch-Stroomann JG; Schröder E; Schümann HJ
    Klin Wochenschr; 1970 Jan; 48(1):36-42. PubMed ID: 5522113
    [No Abstract]   [Full Text] [Related]  

  • 39. [Activity of delta-aminolevulinic acid dehydratase in men occupationally exposed to lead].
    Urbanowicz H; Grabecki J; Sidoroff J; Kucharski R
    Pol Tyg Lek; 1970 Jul; 25(27):1010-2. PubMed ID: 5449553
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of DL-propranolol on delta-aminolevulinic acid synthetase activity and urinary excretion of porphyrins in allylisopropylacetamide-induced experimental porphyria.
    Blum I; Schoenfeld N; Atsmon A
    Biochim Biophys Acta; 1973 Sep; 320(2):242-8. PubMed ID: 4750745
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.